Form 4: Edwards Lifesciences Executive Exercises Options and Sells Shares Under 10b5-1 Plan

Donald E. Bobo Jr., a CVP at Edwards Lifesciences, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Summary

• On April 8, 2024, Donald E. Bobo Jr., CVP of Strategy/Corp Development at Edwards Lifesciences Corp, executed transactions involving the company's common stock.
• Bobo exercised employee stock options to acquire 12,500 shares at a price of $36.75 per share.
• Simultaneously, Bobo sold 100 shares at $92.66 and 12,400 shares at a weighted average price of $92.3287, with prices ranging from $91.645 to $92.640.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on February 2, 2023.
• Following these transactions, Bobo directly owns 52,167.7184 shares of common stock.
• Bobo also indirectly owns 38,544.9007 shares through a 401(k) and 135,152 shares through a trust.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock transactions.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of a 10b5-1 plan indicates that the transactions were pre-planned and not based on any inside information at the time of the trades.

Comparison to Industry Standards

• Executive compensation practices, including stock options and trading plans, are common across publicly traded companies, particularly in the healthcare and medical device sectors.
• Companies like Medtronic, Abbott, and Boston Scientific also utilize similar compensation structures and trading plans for their executives.
• The specifics of option grants, exercise prices, and trading plans vary based on company performance, individual contributions, and overall market conditions.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider trading.
• The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.

Key Dates